treatment
CONCLUSIONS: This first characterization of the coagulation activation induced by       rtPA treatment for acute ischemic stroke and the failure to abolish such       hemostatic abnormalities by heparin may be of value for further refinement of the       currently discussed thrombolytic therapy and the controversial adjunctive       anticoagulant prophylaxis in stroke patients.
CONCLUSIONS: This first characterization of the coagulation activation induced by        @OBJECT$  @PREDICAT$  @SUBJECT$  for acute ischemic stroke and the failure to abolish such       hemostatic abnormalities by heparin may be of value for further refinement of the       currently discussed thrombolytic therapy and the controversial adjunctive       anticoagulant prophylaxis in stroke patients.